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Acute Myocardial Infarction
Abstract
Objectives: We tested the hypothesis that perception of control moderates any relationship between
anxiety and in-hospital complications (i.e., recurrent ischemia, reinfarction, sustained ventricular
tachycardia or fibrillation, and cardiac death) in patients with acute myocardial infarction (AMI).
Background: Anxiety is common among patients with AMI, but whether it is associated with poorer
outcomes is controversial. Conflicting findings about the relationship of anxiety with cardiac morbidity
and mortality may result from failure to consider the moderating effect of perceived control.
Methods: This was a prospective examination of the association among anxiety, perceived control, and
subsequent in-hospital complications among patients (N = 536) hospitalized for AMI.
Results: Patients’ mean anxiety level was double that of the published mean norm. Patients with higher
levels of perceived control had substantially lower anxiety (p = .001). A total of 145 (27%) patients
experienced one or more in-hospital complications. Patients with higher levels of anxiety had significantly
more episodes of ventricular tachycardia, ventricular fibrillation, and reinfarction and ischemia (p < .01 for
all). In a multivariate hierarchical logistic regression model, left ventricular ejection fraction, history of
myocardial infarction, anxiety score, and the interaction of anxiety and perceived control were significant
predictors of complications.
Conclusion: Anxiety during the in-hospital phase of AMI is associated with increased risk for in-hospital
arrhythmic and ischemic complications that is independent of traditional sociodemographic and clinical
risk factors. This relationship is moderated by level of perceived control such that the combination of high
anxiety and low perceived control is associated with the highest risk of complications.
AMI = acute myocardial infarction; CHD = coronary heart disease; BSI = Brief Symptom Inventory; CAS =
Control Attitudes Scale.

Keywords
anxiety, psychological factors, acute myocardial infarction

Disciplines
Cardiology | Cardiovascular Diseases | Circulatory and Respiratory Physiology | Health and Medical
Administration | Medical Humanities | Medicine and Health Sciences | Mental and Social Health |
Neurosciences | Nursing | Psychiatry | Psychiatry and Psychology

Author(s)
Debra K. Moser, Barbara Riegel, Sharon McKinley, Lynn V. Doering, Kyungeh An, and Sharon L. Sheahan

This technical report is available at ScholarlyCommons: https://repository.upenn.edu/nrs/143

Impact of Anxiety and Perceived Control on In-Hospital Complications after Acute
Myocardial Infarction

Short title: Anxiety and AMI Complications

Debra K. Moser, DNSc, RN, FAAN
Professor and Gill Endowed Chair of Nursing, University of Kentucky, College of Nursing
Barbara Riegel, DNSc, CS, RN, FAAN
Associate Professor, University of Pennsylvania, School of Nursing
Sharon McKinley, PhD, RN
Professor, University of Technology, Sydney and Royal North Shore Hospital
Lynn V. Doering, DNSc, RN, FAAN
Associate Professor, University of California, Los Angeles, School of Nursing
Kyungeh An, PhD, RN
Senior Researcher, Kyung Hee University
Sharon Sheahan, PhD, RN
Associate Professor, University of Kentucky, College of Nursing

Total word count: 4943; Number of tables: 3; Number of figures: 2
For correspondence:
Debra K. Moser, DNSc, RN, FAAN
Professor and Linda C. Gill Endowed Chair of Nursing
University of Kentucky, College of Nursing, 527 CON, Lexington, KY 40536-0232
Phone 859-323-6687, FAX 859-323-1057, dmoser@uky.edu

1

Acknowledgements: Funding from University of Kentucky Gill Endowment, Faculty
Research Support and American Association of Critical Care Nurses-Sigma Theta Tau
International Awards

2

Impact of Anxiety and Perceived Control on In-Hospital Complications after Acute
Myocardial Infarction

Debra K. Moser, Barbara Riegel, Sharon McKinley, Lynn V. Doering, Kyungeh An,
Sharon Sheahan

3

Abstract
Objectives: We tested the hypothesis that perception of control moderates any
relationship between anxiety and in-hospital complications (i.e., recurrent ischemia,
reinfarction, sustained ventricular tachycardia or fibrillation, and cardiac death) in acute
myocardial infarction (AMI) patients.
Background: Anxiety is common among AMI patients, but whether it is associated
with poorer outcomes is controversial. Conflicting findings about the relationship of
anxiety with cardiac morbidity and mortality may result from failure to consider the
moderating effect of perceived control.
Methods: This was a prospective examination of the association between anxiety,
perceived control, and subsequent in-hospital complications among patients (N= 536)
hospitalized for AMI.
Results: Patients’ mean anxiety level was double that of the published mean
norm. Patients with higher levels of perceived control had substantially lower anxiety (p <
0.01). A total of 145 (27%) patients experienced one or more in-hospital complications
that comprised the combined end-point. Patients with higher levels of anxiety had
significantly more episodes of ventricular tachycardia, ventricular fibrillation, and
reinfarction and ischemia (p < 0.01 for all). In a multivariate hierarchical logistic
regression model left ventricular ejection fraction, history of previous myocardial
infarction, anxiety score and the interaction of anxiety and perceived control were
significant predictors of complications.
Conclusion: Anxiety during the in-hospital phase of AMI is associated with
increased risk for in-hospital arrhythmic and ischemic complications that is independent of
traditional sociodemographic and clinical risk factors. This relationship is moderated by
level of perceived control such that the combination of high anxiety and low perceived
control is associated with the highest risk of complications.
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Accumulating evidence strongly suggests that psychological and social factors
affect morbidity and mortality among individuals with coronary heart disease (CHD).(1-5)
In particular, depression (6-12) and lack of social support (13-16) have been shown
convincingly to contribute to development of acute cardiac events and CHD mortality.
Anxiety is common and levels are high in persons hospitalized with acute cardiac events
(4,17,18), but the influence of anxiety on subsequent cardiac events and mortality,
particularly in the acute phase of a cardiac event, has not been well characterized.(19-21)
In a small sample, we demonstrated previously that acute myocardial infarction
(AMI) patients with high anxiety had 4.9 times greater risk than patients with lower anxiety
of developing recurrent ischemia, reinfarction, ventricular tachycardia or ventricular
fibrillation during hospitalization.(17) Others have demonstrated that anxiety is an
independent predictor for CHD events,(22-24) and mortality months to years after AMI,
(25,26) although some investigators have reported that anxiety is unrelated to morbidity or
mortality.(21,27-28) Most notably lacking in this area of research is evidence on the
impact of anxiety in the acute (i.e., during hospitalization) stages of myocardial infarction.
Attention to the effect of anxiety within the early hours and days after AMI could yield
substantial early benefits as monitoring and intervention are readily available during
hospitalization.
There are several possible reasons for the disparate findings seen, including
inadequate sample size in some studies, varying conceptual and operational definitions of
anxiety, and use of homogeneous samples within studies, which decreases statistical
power. Another reason may be failure to consider the role of moderators of anxiety in
these studies. That is, there may be important factors that, when present, change the
manner in which anxiety affects outcomes. Identification of factors that moderate any
association between anxiety and poor outcomes is important as such factors are targets
for intervention.
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One potential moderating factor is perceived control.(29-31) Perceived control is
associated with anxiety level.(29,32,33) In a variety of cardiac patients, including heart
failure, AMI, and recovering myocardial infarction and cardiac bypass patients, patients
with higher levels of perceived control compared to those with lower levels have
substantially lower levels of anxiety and other negative emotions.(29-33) Patients with
higher perceived control have a better course after diagnosis of a variety of chronic and/or
life-threatening illnesses.(32,34,35) In addition, investigators have demonstrated that
perceived control can be modified by simple interventions, and that increases in perceived
control predict improved emotional state, including lower anxiety levels. (31)
Accordingly, we tested the hypothesis that level of perceived control moderated the
relationship between anxiety and the development of in-hospital complications in patients
hospitalized for AMI. To overcome limitations of previous studies, we used a large,
heterogeneous sample.
Methods
The investigation was a prospective, comparative examination of the association
between early anxiety, perceived control, and subsequent in-hospital complications.
Patients were enrolled from the cardiac care units of 6 diverse hospitals that included 4
large urban university medical centers and 2 large urban community hospitals in the
United States and Australia.
Patients
Institutional review board approval was obtained at all sites, and all patients gave
signed, informed consent. From January 2001 through December 2002, consecutive
patients were identified by the cardiac care unit manager, educator, or clinical specialist
who briefly explained the study and informed patients that a member of the research team
would explain the study in full, obtain consent and then conduct an interview. Cardiac care
unit patients who met the following criteria were eligible for the study: 1) diagnosis of AMI
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confirmed by elevated cardiac enzymes and typical ECG changes; 2) pain-free and
hemodynamically stable at the time they were approached for inclusion in the study; 3)
free of cognitive impairment that could interfere with ability to provide informed consent
and participate in a short interview; 5) free of noncardiac serious or life-threatening comorbidities such as sepsis, shock, stroke, or acute renal failure.
Protocol and Measurement
Sociodemographic and clinical data (Table 1) were obtained by patient interview
and medical record review. Within 72 hours (median 28 hours) of arrival at the hospital,
patients were interviewed regarding anxiety (36) and perceived control,(30,37) as
described below. Questionnaires were read to them and they were provided with
laminated sheets that contained the possible responses for each questionnaire in very
large type to improve ease of answering. Although patients may have been admitted with
or had hemodynamic compromise after admission, they were pain-free and
hemodynamically stable when interviewed. Complications that occurred subsequent in
time to the interview were abstracted from the medical record by registered nurses who
were cardiac care specialists and who were extensively trained in data collection and
interview techniques. Data extraction included review of every page of each patients’
medical record to determine complications, instead of relying on physician or nurse
documentation of the complication. Patients with complications before the interview were
excluded as the occurrence of complications likely increases anxiety. Nurses collecting
complication data were blinded to the anxiety level of the patient.
Anxiety Measurement
Anxiety was defined conceptually as a feeling of foreboding, dread or threat,
elicited by a real or imagined threat.(38) The anxiety subscale of the Brief Symptom
Inventory (BSI) was used to measure anxiety.(36) The anxiety subscale measures state
(as opposed to trait) anxiety and symptom refers to psychological and not physical
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manifestations. The BSI anxiety subscale was chosen for its brevity, reliability and validity
in medical clinical populations, and its demonstrated sensitivity to anxiety. Construct,
convergent, discriminant, and predictive validity of the BSI have been established in a
series of studies. Internal consistency coefficients for the anxiety subscale are
consistently reported to be higher than 0.80;(17,36,39) in this study, Cronbach’s alpha was
0.87. The anxiety subscale of the BSI has the additional advantage of not using physical
indicators of emotional states that often over-estimate the level of mood states in patients
with physical disease. Each item on the BSI is rated by the patient on a 5-point scale (0-4)
of distress ranging from "not at all" to "extremely". Item scores are summed and the mean
obtained. Thus, the possible range of scores for the anxiety scale is 0 to 4, with higher
scores indicative of higher levels of anxiety. Norm referenced data are available for
comparison.(36)
In order to further validate the use of the BSI in acutely ill patients, we conducted a
psychometric study comparing the reliability and validity of the anxiety subscale of the BSI
with the more established Spielberger State Anxiety Index.(40) We found that the BSI
demonstrated equal or greater reliability and validity in AMI patients than the Spielberger
State Anxiety Index. Patients found the BSI less conceptually challenging than the longer
Spielberger State Anxiety Index and thus easier to understand.
Perceived Control Measurement
Control was defined as the perception or belief that individual’s have a coping
response that can positively influence adverse events or circumstances. Importantly,
control does not need to be exerted and the belief does not need to be realistic. The
Control Attitudes Scale (CAS),(30,37) used to measure perceived control, consists of 4
belief statements measuring perceived control and lack of control, in the context of cardiac
disease. Patients rate their level of agreement with the statements on the CAS using a 7point Likert–type scale. Responses for each item are summed to arrive at a total score,
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which can range from 4 to 28. Instrument reliability as assessed by internal consistency
was high, with a Cronbach's alpha of 0.89. Content, construct, and predictive validity of the
instrument have been demonstrated.(30,31)
Complications
In-hospital complications were defined as the composite endpoint of one or more
of the following: 1) acute recurrent ischemia as evidenced by new onset chest pain with a)
ST segment elevation on bedside ST segment monitor or 12-lead ECG, and/or b)
hemodynamic compromise evidenced by blood pressure or pulse changes from baseline,
and/or c) nitrates and/or intravenous pain medication given for chest pain relief; 2)
reinfarction as evidenced by recurrent positive CK-MB that occurs after an episode of
recurrent chest pain or hemodynamic compromise and after CK-MB or troponin levels
have stopped rising from the initial infarct; 3) sustained ventricular tachycardia (> 15 sec)
or any ventricular tachycardia requiring pharmacologic or electrical intervention due to
hemodynamic compromise and/or chest pain; 4) ventricular fibrillation; or 5) in-hospital
death. These complications were chosen because they are the complications consistent
with the theory that increased anxiety produces enhanced sympathetic nervous system
arousal.
Data Analysis
Data are presented as means ± standard deviations or frequencies and
percentages. To reduce the possibility that any demonstrated association between
increased anxiety level and complications could be explained by severity of myocardial
infarction, or differences in treatment or sociodemographics, differences in baseline
characteristics between higher and lower anxiety patients were examined using Chisquare for categorical variables, Student’s t-tests or Mann-Whitney U for continuous
variables. For these analyses only, patients were split into two groups based on the
median split of anxiety score. In all subsequent analyses, anxiety score was used in its
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raw form. Baseline variables upon which the groups differed were controlled in
subsequent analyses. Mann-Whitney U was used to compare anxiety level between high
control and low control patients.
To explore the association of anxiety, the interaction between anxiety and
perceived control, and other potential covariates with the outcome variable of
complications we used multiple logistic regression. The odds ratios and 95% confidence
intervals for the occurrence of complications in relation to the baseline sociodemographic
(i.e. age, gender), clinical (i.e. history of hypertension, diabetes or previous AMI, type of
infarction, aspirin or beta-blocker administration in the emergency department, anxiolytic
use during hospitalization, left ventricular ejection fraction, admission Killip classification,
peak chest pain level), and psychological (i.e. anxiety score, perceived control) variables
were assessed. To evaluate the prognostic importance of anxiety in relation to other
established measures of risk, we determined the degree to which anxiety score and
perceived control level improved a predictive model of the other significant predictors of
complications. These predictors were entered first into the model followed by the anxietycontrol interaction term.
Results
A total of 540 patients were recruited for the study. Four patients failed to complete
the anxiety assessment instrument and thus the total final sample size was 536 (Table 1).
The only baseline sociodemographic variable that differentiated between patients in the
low and high anxiety groups was age (Table 1). Younger patients reported higher anxiety.
Although there were more women in the high anxiety group compared to the low anxiety
group, this difference did not reach statistical significance. Three clinical variables differed
between the two groups. Patients in the high versus low anxiety group received a betaadrenergic blocking agent, aspirin, or anxiolytic in the emergency department more often
than did those in the low anxiety group (Table 2). There were no differences in treatment
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after the emergency department and during the remainder of the hospitalization between
the two groups with the exception that more patients in the high anxiety group received an
anxiolytic during their hospital stay.
Anxiety and perceived control
The mean anxiety level of patients in this sample (0.66  0.79) was double that of
the published mean from the norm reference group.(36) Nineteen percent of patients
expressed anxiety levels that were at or above those referenced for psychiatric inpatients.(36) The level of perceived control ranged from a low of 4 to a high of 28 (mean
18  5). Although there are no published norms, levels below 16 reflect a low level of
perceived control(30,37) and 41% of patients in this sample had levels lower than 16.
Patients with higher levels of perceived control had substantially lower anxiety than those
with lower levels of perceived control (0.48 ± 0.75 vs 0.79 ± 0.73 p < 0.01).
Anxiety, Perceived Control and Complications.
A total of 145 (27%) patients experienced one or more of the in-hospital
complications that comprised the combined end-point. These complications included 64
unique episodes of ventricular tachycardia, 13 cases of multiple episodes of ventricular
tachycardia, 26 instances of ventricular fibrillation, 110 of recurrent ischemia, 12
reinfarctions, and 7 cardiac deaths. In bivariate analyses, patients with higher levels of
anxiety had significantly more episodes of the combined end-point, and of the following
individual end-points: ventricular tachycardia, ventricular fibrillation, and reinfarction or
ischemia (Figure 1). There were no differences in number of cardiac deaths between
the two groups.
We also stratified the sample by presence of ST segment elevation myocardial
infarction and non ST segment elevation myocardial infarction, and examined the
association between anxiety and in-hospital complications. Patients with higher levels of
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anxiety had more complications than those with lower levels of anxiety regardless of
type of AMI. A total of 31% of ST segment elevation myocardial infarction patients
versus 23% of non ST segment elevation myocardial infarction patients had any inhospital complication (p = 0.01). In-hospital complication rates for patients with ST
segment elevation myocardial infarction were 36% for high anxiety patients versus 23%
for low anxiety patients (p = 0.01). Rates for patients with non ST segment elevation
myocardial infarction were 26% for high anxiety patients versus 15% for low anxiety
patients (p = 0.04).
Of the variables tested in the multivariate hierarchical logistic regression model
(i.e. age, gender, left ventricular ejection fraction, type of myocardial infarction, peak
chest pain level, history of hypertension, diabetes or previous AMI, admission Killip
classification, aspirin or beta-blocker administration in the emergency department,
anxiolytic use during hospitalization, anxiety score, and level of perceived control), left
ventricular ejection fraction, history of previous myocardial infarction, anxiety score and
the interaction of anxiety and perceived control were significant predictors of
complications (Table 3). Patients with a lower ejection fraction, a history of previous
AMI, and a higher level of anxiety had significantly more occurrences of the combined
end-point. In addition, the interaction of anxiety and perceived control was a significant
predictor of complications, indicating that perceived control moderated the relationship
between anxiety and complications. Patients with high anxiety and low perceived control
had the highest occurrence of complications (Figure 2).

Discussion
Results of this multicenter study contribute to the body of literature implicating
anxiety as a risk factor for short- and long-term physical complications after AMI.(25,41)
It is one of the few investigations of the impact of anxiety very early after AMI on in-
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hospital complications. Both ischemic and arrhythmic complications were predicted by
the presence of higher anxiety. Importantly, this relationship was independent of the risk
conferred by a number of traditional clinical factors. Risk stratification after AMI
continues to be driven by clinical variables alone. Results from this study and from
others demonstrating the long-term cardiovascular risks of negative affective states and
social isolation provide further evidence that psychological and social factors should be
considered when assessing risk after AMI and that interventions to decrease anxiety need
to be investigated and applied widely.(5)
Conflicting findings to date about the relationship between anxiety and outcomes in
CHD patients are thought primarily to be the result of two major factors: failure to consider
moderators of anxiety and anxiety measurement ambiguities. Our findings further the
research regarding the role of anxiety in morbidity and mortality outcomes among those
with heart disease by demonstrating the moderating effect of perceived control on the
association between anxiety and in-hospital outcomes. Patients with high levels of anxiety
had significantly more complications than those with low anxiety, but those with the
greatest occurrence of complications were patients with both high anxiety and low
perceived control.
Perceived control is modifiable by a number of simple, but well-timed, wellconstructed, systematically delivered interventions.(31) Such interventions include
education and counseling to reframe an acute cardiac event from an out of control crisis to
the herald of a chronic condition that can be controlled with adherence to recommended
therapy and lifestyle changes.(42,43) Given that the over-riding threat for most individuals
after an acute cardiac event is the perception of a loss of control(44) (45) plus the strong
inverse association between perceived control and anxiety,(29,30,33) aggressive
development and testing of specific intervention approaches targeted at increasing the
perception of control among AMI patients appears warranted.
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With regard to measurement ambiguities that may have clouded the accurate
assessment of the relationship between anxiety and outcomes, the major controversy has
centered around the measurement of clinical anxiety syndromes such as phobic anxiety
versus symptoms of anxiety. Some researchers have contended that it is only clinically
diagnosed anxiety syndromes that are associated with morbidity and mortality outcomes.
However, our previous work(17), the results presented in this study, and the work of others
who have measured anxiety symptoms, but not anxiety syndromes(25,46) and
demonstrated a strong independent association between anxiety and patient outcomes
argues against this stance.
Patients in this study expressed a mean anxiety level that was 50% greater than
the norm reference figure and almost a quarter of patients reported anxiety levels that
exceed those reported by psychiatric in-patients. This was despite the finding that patients
in the higher anxiety group tended to receive an anxiolytic more often in the emergency
department and during hospitalization. These findings highlight the persistent problem of
inadequate assessment and management of anxiety and other psychological problems in
cardiac patients.(47,48) Anxiety can not be treated unless it is first recognized. Without a
formal screening instrument, clinicians are not able to accurately identify psychological
distress in their patients.(47,48) Routine use of a short, simple anxiety assessment
appears warranted in the hospital setting for patients suffering acute cardiac events. A
number of such instruments exist and have been shown to be valid for screening in clinical
settings.(49) The instrument used in this study assesses anxiety using 6 items and has
been shown to perform well in a variety of clinical cardiac settings.(17,50)
The mechanisms whereby anxiety could be associated with morbidity and mortality
outcomes in AMI patients remain unclear. The major theories are that both physiological
and behavioral mechanisms contribute to poor physical outcomes in anxious cardiac
patients.(5) Although behavioral mechanisms (e.g. nonadherence to medications or
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lifestyle change recommendations, adoption or maintenance of risky behaviors such as
smoking or sedentary life-style) likely are important factors that contribute to the
relationship between psychological distress and physical outcomes seen on long-term
follow-up, it is unlikely that they play a major role in precipitating acute cardiac events in
the short-term among AMI patients. A more plausible mechanism linking anxiety with inhospital complications in AMI patients is a physiologic one wherein excess activation of
the sympathetic nervous system results in decreased heart rate variability, increased
platelet aggregation and other changes in coagulation, alterations in fibrillation threshold,
and endothelial dysfunction.(5) Although we did not test mechanisms in this study, the
increased incidence of ischemic and arrhythmic complications seen in patients with higher
anxiety supports the theory that anxiety is associated with excess sympathetic nervous
system activation.
Study Limitations. A potential limitation in this study relates to concerns about
generalizability. The incidence of ST segment elevation myocardial infarction was higher
in this sample than seen in large registries of acute myocardial infarction patients,
suggesting that this sample does not completely reflect the typical proportions of ST
segment elevation myocardial infarction and non-ST segment elevation myocardial
infarction. Our higher proportion of ST segment elevation myocardial infarction is likely
due to our inclusion criteria and the need to identify patients very early in the course of
hospitalization. Nonetheless, our large sample size provided a sufficient number of non
ST segment elevation myocardial infarction patients to allow generalizability to both types
of AMI patients.
Conclusion.
Anxiety during the in-hospital phase of AMI care is associated with an increased
risk for in-hospital arrhythmic and ischemic complications that is independent of a number
of traditional sociodemographic and clinical risk factors. This relationship is moderated by
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level of perceived control such that the combination of high anxiety and low perceived
control is associated with the highest risk. These findings provide specific targets for
intervention to sever the link between anxiety and poor physical outcomes in hospitalized
AMI patients. Assessment for anxiety in hospitalized AMI patients is warranted given the
high levels that exist in this patient population and the potential for adverse outcomes
associated with anxiety.
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Figure Legends

Figure 1. Comparison of in-hospital complication rates by high and low anxiety
groups.

Figure 2. The moderating impact of perceived control on the relationship between
anxiety and complications. Comparison of percentage of patients out of the entire
sample who had complications based on anxiety and perceived control.
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Table 1. Characteristics of the sample of 536 acute myocardial infarction patients
Entire Sample

High Anxiety

Low Anxiety

N = 536

n = 262

n = 274

Sexc
Male

354 (66)

165 (63)

189 (70)

Female

180 (34)

97 (37)

83 (30)

Married/cohabitate

369 (69)

182 (70)

187 (69)

Single/divorced/ widowed

164 (31)

79 (30)

85 (31)

Age, yearsb,*

62  14

60  13

64  13

Education, yearsb

13  3

13  3

13  3

Peak chest pain, scale 0 to 10, 10 =

73

73

73

Peak CK-MB, ng/mld

148  167

151  175

145  160

ST segment elevation myocardial

330 (64)

162 (64)

168 (63)

50  13

51  14

49  13

I/II

485 (92)

234 (91)

251 (92)

III/IV

45 (9)

23 (9)

22 (8)

Marital statusc

worstd

infarctionc
Left ventricular ejection fraction, %b
Admission Killip classc

22

Diabetesc

116 (22)

57 (22)

59 (22)

Hypertensionc

301 (57)

147 (57)

154 (57)

Previous myocardial infarctionc

144 (27)

66 (25)

78 (29)

Admission systolic blood pressure,

141  28

141  28

142  29

81  18

81  18

81  18

79  21

79  19

79  22

mmHgb
Admission diastolic blood pressure,
mmHgb
Admission pulse, beats/minb

Values are n (%) or mean  SD; * p < 0.05 for comparison between high and low anxiety
groups; statistical tests used to compare high vs low anxiety patients were chi-square,c
Student’s t-test,b or Mann-Whitney Ud

23

Table 2. Treatments Received in the Emergency Department and Hospital (n=536)

Entire
Sample

High Anxiety

Low Anxiety

n = 262

n = 274

P*

N = 536

Fibrinolysis in ED

163 (31)

86 (34)

77 (28)

.22

Beta-adrenergic blocking agent in ED

237 (46)

126 (50)

111 (41)

.04

Aspirin in ED

421 (80)

214 (84)

207 (76)

.03

Anxiolytic in ED

168 (32)

92 (37)

76 (28)

.05

Coronary artery bypass grafting

62 (12)

23 (9)

39 (14)

.06

Angioplasty

337 (64)

166 (65)

171 (63)

.65

ACEI during hospitalization

313 (60)

146 (58)

167 (61)

.38

Beta-adrenergic blocking agent during

450 (85)

218 (84)

232 (85)

.81

247 (47)

135 (53)

112 (42)

.01

hospitalization
As needed anxiolytic during
hospitalization
* p value for comparison between high and low anxiety groups; chi-square used for
comparisons; ACEI = Angiotensin converting enzyme inhibitor; ED = emergency
department
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Table 3: Multivariate Hierarchical Logistic Regression for Prediction of In-hospital
Complications
Predictor

Odds Ratio

CI

P

Previous myocardial infarction

1.9

1.1 - 3.3

<0.01

Left ventricular ejection fraction

.97

.96 - .99

<0.01

Anxiety score

1.5

1.1 – 2.0

<0.01

Anxiety score * perceived control

1.3

1.1 – 1.8

<0.01

In a test of the following model: age, sex, hypertension, diabetes, previous myocardial
infarction, left ventricular ejection fraction, type of myocardial infarction, peak pain level,
admission Killip class, aspirin administration in the emergency department, beta-blocker
administration in the emergency department, anxiolytic given during hospitalization, total
anxiety score, perceived control and the interaction of anxiety score and perceived
control
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Figure 1.
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Figure 2.
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